Great Benefit Life Insurance

Great Benefit Life Insurance is a powerful insurer whose claims practices turn delay and denial into a business strategy. Its dispute with the Black family reveals how routine paperwork, divided departments, and calculations about whether customers will seek legal help can make a potentially covered medical claim a source of profit—and how litigation can bring those practices into public view.

Business and Customers

Great Benefit sells debit insurance, inexpensive policies marketed door to door to people with limited incomes. Agents return regularly to collect premiums and record payments in customers’ books. Max Leuberg describes the business as preying on people who are uneducated or wary of lawyers and the legal system, while claimants’ limited resources make challenging a denial difficult.

The low rate of litigation is part of the economic context. Leuberg says studies found that only about one in thirty bad-faith denials resulted in a lawsuit. Cooper Jackson, explaining the claims process to Rudy Baylor, gives a related but distinct figure: the company counted on most customers giving up, with about one in twenty-five consulting a lawyer. In either account, the prospect that many policyholders would not pursue their claims shaped the risks the company faced when it refused payment.

How Denials Work

The company’s internal process begins with a denial rather than a decision made after a complete review. A claims handler sends an initial denial letter, then orders the insured’s medical records from the preceding five years. A later letter may say the claim is denied pending further review. The file then passes to underwriting, whose memo instructs claims not to pay until further notice. More letters and memos follow as the departments dispute policy language and responsibility for the file.

Claims and underwriting work for the same company, yet their limited communication keeps the file circulating between them while the policyholder receives additional correspondence. Jackson describes this separation as intentional. The practical effect is that a claimant can face repeated postponements and denials without a clear route to payment. The company’s Great Benefit claims manual and Great Benefit underwriting manual make the arrangement more concrete: their corresponding Section U procedures direct each department to deny the claim pending review and send it to the other department, where payment is again withheld.

The 1991 Experiment and the Black Claim

Jackie Lemancyzyk testifies that, beginning January 1, 1991, Great Benefit adopted a twelve-month policy of initially denying every claim over $1,000. Some smaller claims were also ultimately denied when the company could find an arguable reason. The policy was not confined to doubtful cases: the initial denial applied regardless of how legitimate the claim was, and larger claims were rarely paid unless the insured hired a lawyer and threatened legal action.

Lemancyzyk characterizes the policy as an experiment in how much money the company could save over a year, after accounting for quick settlements. She says it produced an additional $40 million. The Black claim entered this system as an initial denial. When the file disclosed that Donny Ray Black had acute leukemia, his treatment and the claim came under closer monitoring by senior personnel. The testimony establishes that the policy did not exclude bone marrow transplants and that medical records described the transplant as necessary to prevent the disease from becoming fatal. Lemancyzyk says she showed the prognosis to her supervisors, but the decision was made to continue denying the claim because Great Benefit was playing the odds that the family would not consult a lawyer.

Litigation, Costs, and Corporate Stakes

Great Benefit contests the Black family’s suit through a large legal team. Its counsel seeks to move the case to federal court by arguing that Bobby Ott, the agent who sold the policy, was improperly included as a defendant. The dispute turns on complete diversity of citizenship: because the Black family and Ott are alleged to be Tennessee residents, his presence as a defendant is offered as a reason the case cannot be heard in federal court.

The company also uses the prospective cost of litigation to frame settlement. Leo F. Drummond tells Rudy Baylor that he estimated a full trial defense would cost between $50,000 and $75,000, and that Great Benefit authorized a $75,000 settlement offer. He presents the offer as a way to avoid further defense expense, executive depositions, court appearances, and publicity, while making clear that it includes no admission of liability. The offer puts a dollar value on silence and certainty; the family’s case, by contrast, seeks accountability for the denial as well as compensation.

In his closing argument, Baylor uses figures drawn from the company’s financial statements to show the jury the scale of the defendant’s resources. He calculates $475 million in available cash, reserves, and undistributed surpluses, alongside an admitted net worth of $450 million. He argues that punitive damages must be measured against a corporation’s capacity to absorb a penalty, rather than set at an amount too small to affect its behavior. Great Benefit thus appears in the trial not only as the issuer of a disputed policy but as a wealthy institution whose incentives, internal procedures, and exposure to punishment are all at issue.

Significance

Great Benefit’s claims system makes bureaucratic delay consequential: a file can move between departments while a seriously ill policyholder waits for treatment. The 1991 experiment gives that pattern a deliberate financial rationale, and the Black claim demonstrates how the company’s general policy reaches an individual family. In court, the same separation that obscures responsibility inside the company becomes evidence of an organized process, while the company’s resources sharpen the question of whether a damages award can deter profitable denial.